SCHEMBL1223262

SCHEMBL1223262

O=C(O)n1cccc1-c1ccc2c(c1)C1(CCCCC1)C(=O)N2

nearest known ligand 0.55

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
PGR P06401 16/20 0.55
PDE4A P27815 4/20 0.46
PDE4B Q07343 4/20 0.46
PDE4C Q08493 4/20 0.46
PDE4D Q08499 4/20 0.46
PDE3B Q13370 4/20 0.46
PDE3A Q14432 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1222740 0.99 PGR (0.55) PGRPDE4APDE4BPDE4CPDE4D
SCHEMBL3518152 0.86 PGR (0.72) PGRPDE4APDE4BPDE4CPDE4D
SCHEMBL3521249 0.84 PGR (0.61) PGRPDE4APDE4BPDE4CPDE4D
SCHEMBL7128459 0.82 PGR (0.44) PGRPDE4APDE4BPDE4CPDE4D
SCHEMBL5230464 0.81 PGR (0.53) PGRPDE4APDE4BPDE4CPDE4D
SCHEMBL6408891 0.76 PGR (0.73) PGRPDE4APDE4BPDE4CPDE4D
SCHEMBL6433927 0.75 PGR (0.72) PGRPDE4APDE4BPDE4CPDE4D
SCHEMBL3521215 0.75 PGR (0.56) PGRPDE4APDE4BPDE4CPDE4D
SCHEMBL3522548 0.73 PGR (0.56) PGRPDE4APDE4BPDE4CPDE4D
SCHEMBL3990700 0.73 PGR (0.58) PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476262-B2 Cyanopyrroles WYETH LLC (US) 2013-07-02 US disclosed
US-20110039839-A1 Cyanopyrroles WYETH LLC (US) 2011-02-17 US disclosed
US-7846924-B2 Cyanopyrroles WYETH LLC (US) 2010-12-07 US disclosed
US-7645761-B2 Indoline derivatives WYETH (US) 2010-01-12 US disclosed
US-20070259944-A1 Indoline derivatives WYETH (US) 2007-11-08 US disclosed
US-7253203-B2 Indoline derivatives WYETH (US) 2007-08-07 US disclosed
EP-1175398-B1 INDOLINE DERIVATIVES AS PROGESTERONE ANTAGONISTS WYETH CORP (US) 2007-07-11 EP disclosed
US-7091234-B2 Thio-oxindole derivatives WYETH (US) 2006-08-15 US disclosed
US-7084168-B2 Indoline derivatives WYETH (US) 2006-08-01 US disclosed
US-20060160882-A1 Indoline derivatives WYETH (US) 2006-07-20 US disclosed
US-20020169198-A1 Thio-oxindole derivatives WYETH (US) 2002-11-14 US disclosed
US-6462032-B1 Cyclic regimens utilizing indoline derivatives WYETH 2002-10-08 US disclosed
US-20020103248-A1 Thio-oxindole derivatives WYETH LLC 2002-08-01 US disclosed
US-20020086874-A1 Indoline derivatives AMERICAN HOME PRODUCTS CORPORATION (US) 2002-07-04 US disclosed
US-6407101-B1 PROGESTERONE RECEPTOR ANTAGONISTS; CONTRACEPTIVES, HORMONE REPLACEMENT THERAPY; BREAST AND PROSTATE CANCER TREATMENT; MENOPAUSE AMERICAN HOME PRODUCTS CORPORATION 2002-06-18 US disclosed
US-20020068735-A1 Cyanopyrroles AMERICAN HOME PRODUCTS CORPORATION 2002-06-06 US disclosed
US-6391907-B1 ANTICANCER AGENTS; CONTRACEPTIVES AMERICAN HOME PRODUCTS CORPORATION 2002-05-21 US disclosed
US-6355648-B1 COMPOUNDS AS CONTRACEPTIVES AND PROGESTERONE ANTAGONIST AMERICAN HOME PRODUCTS CORPORATION 2002-03-12 US disclosed
EP-1175398-A1 INDOLINE DERIVATIVES AS PROGESTERONE ANTAGONISTS American Home Products Corporation (US) 2002-01-30 EP disclosed
WO-2000066556-A1 INDOLINE DERIVATIVES AS PROGESTERONE ANTAGONISTS AMERICAN HOME PRODUCTS CORPORATION (US) 2000-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110039839-A1 Cyanopyrroles PGR, MC2R, THRB PGR 1/4885PDE4A 2009/4885PDE4B 2217/4885
US-20020068735-A1 Cyanopyrroles PGR, NR3C2, GNRHR PGR 1/4885PDE4A 1641/4885PDE4B 1613/4885
US-20070259944-A1 Indoline derivatives PGR, GNRHR, PRLHR PGR 1/4885PDE4A 2487/4885PDE4B 3175/4885
US-20020103248-A1 Thio-oxindole derivatives PGR, OXTR, PGRMC1 PGR 1/4885PDE4A 2297/4885PDE4B 3114/4885
US-20020086874-A1 Indoline derivatives PGR, GNRHR, PRLHR PGR 1/4885PDE4A 3088/4885PDE4B 3647/4885
US-20060160882-A1 Indoline derivatives PGR, GNRHR, PRLHR PGR 1/4885PDE4A 2487/4885PDE4B 3175/4885
US-20020169198-A1 Thio-oxindole derivatives GPER1, PGR, ESR1 PGR 2/4885PDE4A 3580/4885PDE4B 4089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.